Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Pharmaceutical Research|August 24, 2000
Morphine antinociception is enhanced in mdr1a gene-deficient miceJ Zong, G M PollackPharmaceutical Research|April 1, 1999
Enhanced antinociception of the model opioid peptide [D-penicillamine] enkephalin by P-glycoprotein modulationC Chen, G M PollackThe Journal of Pharmacology and Experimental Therapeutics|November 10, 1998
Altered disposition and antinociception of [D-penicillamine(2,5)] enkephalin in mdr1a-gene-deficient miceC Chen, G M PollackThe Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Blood-brain disposition and antinociceptive effects of -D-penicillamine2,5-enkephalin in the mouseC Chen, G M PollackJournal of Chromatography. B, Biomedical Applications|June 7, 1996
Development of a capillary zone electrophoresis assay to examine the disposition of [D-pen2,5]enkephalin in ratsC Chen, G M PollackPharmaceutical Research|March 1, 1997
Extensive biliary excretion of the model opioid peptide [D-PEN2,5] enkephalin in ratsC Chen, G M PollackAdvanced Drug Delivery Reviews|December 8, 2000
Microdialysis and drug delivery to the eyeK D Rittenhouse, G M PollackJournal of Pharmaceutical Sciences|January 1, 1984
Effect of renal failure and bis(2-ethylhexyl) phthalate pretreatment on the disposition and metabolism of antipyrine in the ratG M Pollack, D D ShenBiopharmaceutics & Drug Disposition|May 1, 1993
Pharmacokinetics and pharmacodynamics of valproate analogs in rats. II. Pharmacokinetics of octanoic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acidM J Liu, G M PollackDrug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 1995
Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in ratsD M Ouellet, G M PollackPageof 9